Physiological and pathological roles of interleukin-6 in the central nervous system

Molecular Neurobiology

Volumn 15, Issue 3, 1997, Pages 307-339

  Gruol, D L ^a   Nelson, T E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Central nervous system; CNS disease; CNS inflammation; Cytokine; Interleukin 6; Neuroimmune; Neuron; Neuropathology

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; FEVER; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; FEVER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; MODELS, NEUROLOGICAL; PITUITARY-ADRENAL SYSTEM; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION;

EID: 0031301027     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740665     Document Type: Article

References (215)

1. Achim C. L., Heyes M. P., and Wiley C. A. (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91, 2769-2775.
2. + neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurology 136, 44-52.
3. Akira S., Hirano T., Taga T., and Kishimoto T. (1990) Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4, 2860-2867.
4. Akira S. and Kishimoto T. (1992) IL-6 and NF-IL6 in acute phase response and viral infection. Immunol. Rev. 127, 25-50.
5. Akira S., Yoshida K., Tanaka T., Taga T., and Kishimoto T. (1995) Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol. Rev. 148, 221-253.
6. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., and Peschle C. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J. Immunol. 149, 2358-2366.
7. Barres B. A., Schmid R., Sendnter M., and Raff MC. (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
8. Bauer J., Strauss S., Schrieler-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., and Berger M. (1991) Interleukin-6 and α2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
9. Bazan J. F. (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934-6938.
10. Bellinger F. P., Madamba S. G., Campbell I. L., and Siggins G. R. (1995) Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198, 95-98.
11. Benveniste E. N. (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263, C1-C16.
12. Benveniste E. N., Sparacio S. M., Norris J. G., Grenett H. E., and Fuller G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201-212.
13. Benveniste E. N., Kwon J., Chung W. J., Sampson J., Pandya K., and Tang L. P. (1994) Differential modulation of astrocyte cytokine gene expression by TGF-β. J. Immunol. 153, 5210-5221.
14. Benveniste E. N., Huneycutt B., Shirikant P., and Ballestas M. E. (1995) Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behavior Immunity 9, 304-314.
15. Berkenbosch F., Biewenga J., Brouns M., Rozemuller J. M., Stirjobos P., and van Dam A.-M. (1992) Cytokines and inflammatory proteins in Alzheimer's disease. Res. Immunol. 143, 657-663.
16. Besedovsky H., Sorkin E., Keller M., and Muller J. (1975) Changes in blood hormone levels during the immune response. Proc. Soc. Exp. Biol. Med. 150, 466-470.
17. Blatteis C. M. (1988) Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. Int. J. Neurosci. 38, 223-232.
18. Blatteis C. M., Quan N., Xin L., and Ungar A. L. (1990) Neuromodulation of acute-phase responses to interleukin-6 in guinea pigs. Brain Res. Bull. 25, 895-901.
19. Blatteis C. M., Xin L., and Quan N. (1991) Neuromodulation off ever: apparent involvement of opioids. Brain Res. Bull. 26, 219-223.
20. Boyd D. and Beckwith J. (1990) The role of charged amino acids in the localization of secreted and membrane proteins. Cell 62, 1031-1033.
21. Brett F. M., Mizisin A. P., Powell H. C., and Campbell I. L. (1996) Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 54(6), 766-775.
22. Burgard E. C., Decker G., and Sarvey J. M. (1989) NMDA receptor antagonists block norepinephrine-induced long-lasting potentiation and long-term potentiation in rat dentate gyrus. Brain Res. 482, 351-355.
23. Buzsaki G., Ponomareff G. L., Bayardo F., Ruiz R., and Gage F. H. (1989) Neuronal activity in the subcortically denervated hippocampus: a chronic model for epilepsy. Neuroscience 28, 527- 538.
24. Cadman E. D., Witte D. G., and Lee C-M. (1994) Regulation of the release of interleukin-6 from human astrocytoma cells. J. Neurochem. 63, 980-987.
25. Campbell I. L. (1996) Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 13(3/4), 275-284.
26. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., and Mucke L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.
27. Campbell I. L. and Chiang C.-S. (1996) Cytokine involvement in central nervous system disease. Implications from transgenic mice. Ann. NY Acad. Sci. 771, 301-312.
28. Carmeliet P., Vankelecom H., Van Damme J., Billiau A., and Denef C. (1991) Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology 53, 29-34.
29. Chai Z., Gatti S., Toniatti C., Poli V., and Bartfai T. (1996) Interleukin-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: a study on IL-6-deficient mice. J. Exp. Med. 183, 311-316.
30. Chiang C-S., Stalder A., Samimi A., and Campbell I. L. (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16, 212-221.
31. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
32. Di Santo E., Alonzi T., Fattori E., Poli V., Ciliberto G., Sironi M., Ricciardi-Castagnoli P., and Ghezzi P. (1996) Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res. 740, 239-244.
33. Dickson D. W., Mattiace L. A., Kure K., Hutchins K., Lyman W. D., and Brosnan C. (1991) Microglia in human disease, with emphasis on acquired immune deficiency syndrome. Lab. Invest. 64, 135-156.
34. Dinarello C. A. (1989) Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44, 153-205.
35. Dinarello C. A., Cannon J. G., Mancilla J., Bishai I., Lees J., and Coceani F. (1991) Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res. 562, 199-206.
36. Dunn A. J., Powell M. L., Meitin C., and Small P. A., Jr. (1989) Virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan. Physiol. Behav. 45, 591-594.
37. Dunn A. J. and Wang J. (1995) Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2, 319-328.
38. Eddleston M. and Mucke L. (1993) Molecular profile of reactive astrocytes-implications of their role in neurologic diesase. Neuroscience 54, 15-36.
39. Ershler W. B., Sun W. H., and Binkley N. (1994) The role of interleukin-6 in certain age-related diseases. Drugs Aging 5, 358-365.
40. Fabry Z., Fitzsimmons K. M., Herlein J. A., Moninger T. O., Dobbs B. M., and Hart M. N. (1993) Production ion of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 47, 23-34.
41. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., and Ciliberto G. (1995) IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7, 2441-2449.
42. 2b receptors mediate an increase in interleukin (IL)-6 protein synthesis in human astroglioma cells. J. Neurochem. 66, 1426-1431.
43. Frei K., Leist T. P., Meager A., Gallo P., Leppert D., Zinkernagel R. M., and Fontana A. (1988) Production of B cell stimulatory factor-2 and Interferon γ in the central nervous system during viral meningitis and encephalitis. J. Exp. Med. 168, 449-153.
44. Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M. E., and Fontana A. (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19, 689-694.
45. Gadient R. A. and Otten U. (1993) Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett. 13-16.
46. Gadient R. A. and Otten U. (1994a) Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637, 10-14.
47. Gadient R. A. and Otten U. (1994b) Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182, 243-246.
48. Gadient R. A. and Otten U. (1995) Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system. Ann. NY Acad. Sci. 762, 403-406.
49. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., and Fontana A. (1989) Human immunodeficiency type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23, 109-116.
50. Gallo P., Laverda A. M., De Rossi A., Pagni S., Del Mistro A., Cago P., Piccinno M. G., Plebani A., Tavolato B., and Bianchi-C. L. (1991) Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Pædiatr Scand. 80, 659-666.
51. Gehrmann J., Matsumoto Y., and Kreutzberg G. W. (1995) Microglia: intrinsic immunoeffector cell of the brain. Brain Res. Rev. 20, 269-286.
52. Gijbels K., Van Damme J., Proost P., Put W., Carton H., and Billiau A. (1990) Interleukin-6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 20, 233-235.
53. Gillies G. E., Linton E. A., and Lowry P. J. (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299, 355-357.
54. Gitter B. D., Regoli D., Howbert J. J., Glasebrook A. L., and Waters D. C. (1994) Interleukin-6 secretion from human astrocytoma cells induced by substance P. J. Neuroimmunol. 51, 101-108.
55. Giulian D. and Baker T. J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
56. Giulian D. (1987) Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18, 155-171.
57. Gottschall P. E., Yu X., and Bing B. (1995) Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 42, 335-342.
58. Grimaldi M., Pozzoli G., Navarra P., Preziosi P., and Schettini G. (1994) Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin independent mechanism. J. Neurochem. 63, 344-350.
59. Hama T., Miyamoto M., Tsukui H., Nishio C., and Hatanaka H. (1989) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104, 340-344.
60. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., and Hatanaka H. (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week old rats in cultures. Neuroscience 40, 445-452.
61. Harbuz M. S., Stephanou A., Sarlis N., and Lightman S. L. (1992) The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. J. Endocrinol. 133, 349-355.
62. Hariri R. J., Chang V. A., Barie P. S., Wang R. S., Sharif S. F., and Ghajar J. B. G. (1994) Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res. 636, 139-142.
63. Helfgott D. C., Tatter S. B., Santhanan U., Clarick R. H., Bhardwaj N., May L. T., and Sehgal P. B. (1989) Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection. J. Immunol. 142, 948-953.
64. Heyes M. P., Saito K., Milstien S., and Schiff S. J. (1995) Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J. Neurol. Sci. 133, 112-118.
65. Heyser C. J., Masliah E., Samimi A., Campbell I. L., and Gold L. H. (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA 94, 1500-1505.
66. Hibi M., Murakami M., Saito M., Hirano T., Taga T., and Kishimoto T. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157.
67. Hickey W. F. and Kimura H. (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292.
68. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., and Kishimoto T. (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA 85, 5490-5494.
69. Hirohata S. and Miyamoto T. (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33, 644-649.
70. Holliday J., Parsons K., Curry J., Lee S. Y., and Gruol D. L. (1995) Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res. 673, 141-148.
71. Holmes M. C., Antoni F. A., Aguilera G., and Catt K. J. (1986) Magnocellular axons in passage through the median eminence release vasopressin. Nature 319, 326-329.
72. Hopkins S. J. and Rothwell N. J. (1995) Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 18, 83-88.
73. Houssiau F. A., Bukasa K., Sindic C. J. M., Van Damme J., and Van Snick J. (1988) Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. Exp. Immunol. 71, 320-323.
74. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 89, 554-551.
75. Hull M., Strauss S., Berger M., Volk B., and Bauer J. (1996) Inflammatory mechanisms in Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 246, 124-128.
76. Hull M., Strauss S., Berger M., Volk B., and Bauer J. (1996) The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78, 37-41.
77. Jander S., Kraemer M., Schroeter M., Witte O. W., and Stoll G. (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15, 42-51.
78. Jonakait G. M. (1997) Cytokines in neuronal development. Adv. Pharmacol 37, 35-67.
79. Kahn M. A. and De Vellis J. (1994) Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12, 87-98.
80. Kasahara T., Yagisawa H., Yamashita K., Yamaguchi Y., and Akiyama Y. (1990) IL1 induces proliferation and IL6 mRNA expression in human astrocytoma cell line: positive and negative modulation by cholera toxin and cAMP. Biochem. Biophys. Res. Comm. 167, 1242-1248.
81. Kishimoto T. (1992) Interleukin-6 and its receptor; from cloning to clinic. Int. Arch. Allergy Immunol. 99, 172-177.
82. Kishimoto T., Akira S., and Taga T. (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258, 593-597.
83. Kishimoto T., Taga T., and Akira S. (1994) Cytokine signal transduction. Cell 76, 253-262.
84. Kishimoto T., Akira S., Narazaki M., and Taga T. (1995) Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
85. Klir J. J., Roth J., Szelenyi Z., McClellan J. L., and Kluger M. J. (1993) Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am. J. Physiol. 265, R512-R517.
86. Klir J. J., McClellan J. L., and Kluger M. J. (1994) Interleukin-1 beta causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am. J. Physiol. 266, R1845-R1848.
87. Kossmann T., Hans V. H. J., Imhof H-G., Stocker R., Grob P., Trentz O., and Morganti-K. M. C. (1995) Intrathecal and serum interleukin-6 and the acute phase response in patients with severe traumatic brain injuries. Shock 4, 311-317.
88. Kossmann T., Hans V., Imhof H-G., Trentz O., and Morganti-K. C. (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713, 143-152.
89. Kushima Y., Hama T., and Hatanaka H. (1992) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci. Res. 13, 267-280.
90. Lafortune L., Nalbantoglu J., and Antel J. P. (1996) Expression of tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J. Neuropathol. Exp. Neurol. 55, 515-521.
91. Lahtinen H., Miettinen R., Ylinen A., Halonen T., and Riekkinen P. J. (1993) Biochemical and morphological changes in the rat hippocampus following transaction of the fimbria-fornix. Brain Res. Bull. 31, 311-318.
92. Lee S. C., Liu W., Dickson D. W., Brosnan C. F., and Berman J. W. (1993) Cytokine production by human fetal microglia and astrocytes. J. Immunol. 150, 2659-2667.
93. LeMay D. R., LeMay L. G., Kluger M. J., and D'Alecy L. G. (1990b) Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am. J. Physiol. 259, R126-R132.
94. LeMay L. G., Vander A. J., and Kluger M. J. (1990) Role of interleukin 6 in fever in rats. Am. J. Physiol 258, R798-R803.
95. LeMay L. G., Otterness I. G., Vander A. J., and Kluger M. J. (1990a) In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine 2, 199-204.
96. Leppert D., Frei K., Gallo P., Yasargil M. G., Hess K., Baumgartner G., and Fontana A. (1989) Brain tumors: detection of B-cell stimulatory factor-2/ interleukin-6 in the absence of oligoclonal bands of immunoglobulins. J. Neuroimmunol. 24, 259-264.
97. Lesnikov V. A., Efremov O. M., Korneva E. A., Van Damme J., and Billiau A. (1991) Fever produced by intrahypothalamic injection of interleukin-1 and interleukin-6. Cytokine 3, 195-198.
98. Lieb K., Kaltschmidt C., Baeuerle P. A., Berger M., Bauer J., and Fiebich B. L. (1996) Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor α genes in the human astrocytoma cell line U373. J. Neurochem. 66, 1496-1503.
99. Lieberman A. P., Pitha P. M., Shin H. S., and Shin M. I. (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86, 6348-6352.
100. Liu J. P., Robinson P. J., Funder J. W., and Engler D. (1990) The biosynthesis and secretion of adrenocorticotropin by the ovine anterior pituitary is predominantly regulated by arginine vasopressin (AVP). Evidence that protein kinase C mediates the action of AVP. J. Biol. Chem. 265, 14136-14142.
101. Luheshi G. and Rothwell N. (1996) Cytokines and fever. Int. Arch. Allergy Immunol. 109, 301-307.
102. Luheshi G., Miller A. J., Brouwer S., Dascombe M. J., Rothwell N. J., and Hopkins S. J. (1996) Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 270, E91-E95.
103. Lust J. A., Donavan K. A., Kline M. P., Greipp P. R., Kyle R. A., and Maihle N.J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96-100.
104. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S., Ohtsuki T., Kinoshita T., Kamada T., and Stern D. M. (1994) Hypoxia/ reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180, 2297-2308.
105. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., and Annunziata P. (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1β and TNFα. J. Neuroimmunol. 47, 73-82.
106. Mastorakos G., Chrousos G. P., and Weber J. S. (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77, 1690-1694.
107. Matta S. G., Weatherbee J., and Sharp B. M. (1992) A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta. Neuroendocrinology 56, 516-525.
108. Mathiesen T., Andersson B., Loftenius A., and von Holst H. (1993) Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J. Neurosurg. 78, 562-567.
109. Matsuzono Y., Narita M., Akutsu Y., and Togashi T. (1995) Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Pædiatr. 84, 879-883.
110. McDuffie R. S., Jr., Sherman M. P., and Gibbs R. S. (1992) Amniotic fluid tumor necrosis factor-alpha and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am. J. Obst. Gynecol 167, 1583-1588.
111. Merrill J. E. (1992) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunotherapy 12, 167-170.
112. Milton A. S. (1989) Thermoregulatory actions of eicosanoids in the central nervous system with particular regard to the pathogenesis of fever. Ann. NY Acad. Sci. 559, 392-410.
113. Minami M., Kruaishi Y., and Satoh M. (1991) Effects of kainic acid on messenger RNA levels of IL-1β TNFα and LIF in the rat brain. Biochem. Biophys. Res. Comm. 176, 593-598.
114. Miyajima A., Kitamura T., Harada N., Yokota T., and Arai K. (1992) Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10, 295-331.
115. Mizuno T., Sawada M., Suzumura A., and Marunouchi T. (1994) Expression of cytokines during glial differentiation. Brain Res. 656, 141-146.
116. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., and Nagatsu T. (1994) Interleukin-1β interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147-150.
117. Mucke L., Masliah E., and Campbell I. L. (1996) Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 202, 187-205.
118. Murakami M., Hibi M., Nakagawa N., Taga T., and Kishimoto T. (1993) IL-6 induced homodimerization of gp130 and associated activation of tyrosine kinase. Science 260, 1808-1810.
119. Nagra R. M., Heyes M. P., and Wiley C. A. (1994) Viral load and its relationship to quinolinic acid, TNFα, and IL-6 levels in the CNS of retroviral infected mice. Mol. Chem. Neuropath. 22, 143-160.
120. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., and Imura H. (1988) Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Comm. 155, 1459-1463.
121. Nakafuku M., Satoh T., and Kaziro Y. (1992) Differentiation factors, including nerve growth factor, fibroblast growth factor and interleukin-6, induce an accumulation of an active Ras GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 267, 19448-19454.
122. 2) production by HIV. J. Immunol. 142, 531-536.
123. Narazaki M., Witthuhn B. A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J. N., Kishimoto T., and Taga T. (1994) Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 91, 2285-2289.
124. Navarra P., Tsagarakis S., Faria M. S., Rees L. H., Besser G. M., and Grossman A. B. (1991) Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128, 37-44.
125. Navikas V. and Link H. (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45, 322-333.
126. Nelson T. E., Campbell I. L., and Gruol D. L. (1997) Altered physiology of Purkinje neurons in cerebellar slices from transgenic mice with chronic central nervous system expression of interleukin-6. (submitted).
127. Nesbit J. E. and Fuller G. M. (1992) Dynamics of interleukin-6 internalization and degradation in rat hepatocytes. J. Biol. Chem. 267, 5739-5742.
128. Norris J. G. and Benveniste E. N. (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J. Neuroimmunol. 45, 137-146.
129. Norris J. G., Tang L-P., Sparacio S. M., and Benveniste E. N. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J. Immunol. 152, 841-850.
130. Opp M., Obal F., Jr., Cady A. B., Johannsen L., and Krueger J. M. (1989) Interleukin-6 is pyrogenic but not somnogenic. Physiol. Behav. 45, 1069-1072.
131. Palma C., Goso C., and Manzini S. (1994) Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line. Neurosci. Lett. 171, 221-224.
132. Perlstein R. S., Mougey E. H., Jackson W. E., and Neta R. (1991) Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 10, 141-146.
133. Perlstein R. S., Whitnall M. H., Abrams J. S., Mougey E. H., and Neta R. (1993) Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132, 946-952.
134. Perrella O., Carrieri P. B., Guarnaccia D., and Soscia M. (1992a) Cerebrospinal fluid cytokines in AIDS dementia complex. J. Neurol. 239, 387-388.
135. Perrella O., Liguori G., Martrinella M., Finelli L., Guarnaccia D., Caiazzo A. L., Buonanno L., Guerriero M., Soscia M., and Marinelli P. (1992b) Cytokine levels in serum and cerebrospinal fluid during tetanus: possible immune activation. Int. J. Immunophathol. Pharmac. 5, 51-56.
136. Perry V. H., Andersson P-B., and Gordon S. (1993) Macrophages and inflammation in the central nervous system. Trends Neurosci. 16, 268-273.
137. Pousset F. (1994) Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev. Brain Res. 81, 143-146.
138. Qiu Z., Parsons K. L., and Gruol D. L. (1995) Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J. Neurosci. 15, 6688-6699.
139. Qiu Z., Netzeband J., and Gruol D. L. (1997) Chronic exposure to interleukin-6 during development enhances NMDA receptor-mediated responses and neurotoxicity in CNS neurons, (submitted).
140. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Donini S. D., and Ricciardi-C. P. (1989) Monokine production by microglial cell clones. Eur. J. Immunol. 19, 1443-1448.
141. Ringheim G. E., Burgher K. L., and Heroux J. A. (1995) Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63, 113-123.
142. Rodriguez M., Pavelko D. K., McKinney C. W., and Leibowitz J. L. (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153, 3811-3821.
143. Romero R., Brody D. T., Oyarzun E., Mazor M., Wu Y. K., Hobbins J. C., and Durum S. K. (1989) Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am. J. Obst. Gynecol. 160, 1117-1123.
144. Romero R., Mazor M., and Tartakovsky B. (1991) Systemic administration of interleukin-1 induces preterm parturition in mice. Am. J. Obst. Gynecol. 165, 969-971.
145. Romero L. I., Schettini G., Lechan R. M., Dinarello C. A., and Reichlin S. (1993) Bacterial lipopolysaccharide induction of IL-6 in rat telencephalic cells is mediated in part by IL-1. Neuroendocrinol. 57, 892-897.
146. Rose-John S. and Heinrich P. C. (1996) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
147. Roth J., Conn C. A., Kluger M. J., and Zeisberger E. (1993) Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am. J. Physiol. 265, R653-R658.
148. Rothman S. M. and Olney J. W. (1995) Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci. 18, 57-58.
149. Rothwell N. J. (1990) Central activation of thermogenesis by prostaglandins: dependence on CRF. Horm. Metab. Res. 22, 616-618.
150. Rothwell N. J. (1994) CNS regulation of thermogenesis. Crit. Rev. Neurobiol. 8, 1-10.
151. Rothwell N. J., Busbridge N. J., Lefeuvre R. A., Hardwick A. J., and Gauldie J. (1991) Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can. J. Physiol. Pharmacol. 69, 1465-1469.
152. Rothwell N. J., Hardwick A., Lefeuvre R. A., Crosby S. R., and White A. (1991) Central actions of CRF on thermogenesis are mediated by proopiomelanocortin products. Brain Res. 541, 89-92.
153. Rotondo D., Abul H. T., Milton A. S., and Davidson J. (1988) Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever. Eur. J. Pharmacol. 154, 145-152.
154. Rott O., Tontsch U., Fleisher B., and Cash E. (1993) Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells. Eur. J. Immunol. 23, 1987-1991.
155. Rubio N. and Sierra A. (1993) Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus. Glia 9, 41-47.
156. Saito K., Suyama K., Nishida K., Sei Y., and Basel A. S. (1996) Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206, 149-152.
157. Satoh M., Nakamura S., Taga T., Hirano T., Kishimoto T., and Kaziro Y. (1988) Induction of neuronal differentiation in PC 12 cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell Biol. 8, 3546-3549.
158. Satoh T., Nakafuku M., and Kaziro Y. (1992) Function of Ras as a molecular switch in signal transduction. J. Biol. Chem. 267, 24149-24152.
159. Sawada M., Suzumura A., and Marunouchi T. (1992) TNFα induces IL-6 production by astrocytes but not by microglia. Brain Res. 583, 296-299.
160. Sawada M., Itoh Y., Suzumura A., and Marunouchi T. (1993) Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett. 160, 131-134.
161. Sawada M., Suzumura A., and Marunouchi T. (1995) Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int. J. Neurosci. 13, 253-264.
162. Schobitz B., Voorhuis D. A. M., and De Kloet E. R. (1992) Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci. Lett. 136, 189-192.
163. Schobitz B., De Kloet E. R., Sutanto W., and Holsboer F. (1993) Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5, 1426-1435.
164. Schobitz B., De Kloet E. R., and Holsboer F. (1994) Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
165. Sebire G., Emilie D., Wallon C., Hery C., Devergne O., Delfraissy J-F., Galanaud P., and Tardieu M. (1993) In vitro production of IL-6, IL-1β and tumor necrosis factor-α by human embryonic microglial and neural cells. J. Immunol. 150, 1517-1523.
166. Sebire G., Delfraissy J-F., Demotes-Mainard J., Oteifeh A., Emilie D., and Tardieu M. (1996) Interleukin-13 and interleukin-4 act as interleukin-6 inducers in human microglial cells. Cytokine 8, 636-641.
167. Sehgal P. B. (1990) Interleukin-6: molecular pathophysiology. J. Invest. Dermatol. 94 (suppl. 6), 2S-6S.
168. Sopper S., Demuth M., Stahl-Hennig C., Hunsmann G., Plesker R., Coulibaly C., Czub S., Ceska M., Koutsilieri W., Riederer P., Brinkmann R., Katz M., and Meulen T. V. (1996) The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 220, 320-329.
169. Spangelo B. L., Judd A. M., Isakson P. C., and MacLeod R. M. (1989) Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125, 575-577.
170. Spangelo B. L., Isakson P. C., and MacLeod R. M. (1990) Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology 127, 403-409.
171. Spangelo B. L., Judd A. M., MacLeod R. M., Goodman D. W., and Isakson P. C. (1990a) Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127, 1779-1785.
172. Spangelo B. L., MacLeod R. M., and Isakson P. C. (1990b) Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology 126, 582-586.
173. Stahl N. and Yancopoulos G. D. (1993) The alphas, betas, and kinases of cytokine receptor complexes. Cell 74, 587-590.
174. Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J. N., and Yancopoulos G. D. (1994) Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 263, 92-95.
175. Stahl N., Farruggella T. J., Boulton T. G., Shong Z., Darnell J. E., and Yancopoulos G. D. (1995) Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353.
176. Steffensen S. C., Campbell I. L., and Henriksen S. J. (1994) Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652, 149-153.
177. Stouthard J. M., Romijn J. A., van der Poll T., Endert E., Klein S., Bakker P. J., Veenhof C. H., and Sauerwein H. P. (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268, E813-E819.
178. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
179. Strijbos P. J., Hardwick A. J., Relton J. K., Carey F., and Rothwell N. J. (1992) Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am. J. Physiol. 263, E632-E636.
180. Suzumura A., Sawada M., and Marunouchi T. (1996) Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor. Brain Res. 713, 192-198.
181. Taga T. (1996) gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. 67, 1-10.
182. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., and Kishimoto T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573-561.
183. Taga T. and Kishimoto T. (1992) Cytokine receptors and signal transduction. FASEB J. 6, 3387-3396.
184. Taniguchi T. (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255.
185. Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S., and Tarkowski A. (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26, 1393-1398.
186. Taupin V., Toulmond S., Serrano A., Benavides J., and Zavala F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J. Neuroimmunol. 42, 177-186.
187. Thomas W. E. (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res. Rev. 17, 61-74.
188. Toulmond S., Vige X., Page D., and Benavides J. (1992) Local infusion of interleukin-6 attenuates the neurotoxic efects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144, 49-52.
189. Tramu G., Croix C., and Pillez A. (1983) Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats. Neuroendocrinology 37, 467-469.
190. Trautwein C., Caelles C., van der Geer P., Hunter T., Karin M., and Chojkier M. (1993) Transactivation by NF-IL-6/LAP is enhanced by phosphorylation of its activation domain. Nature 364, 544-547.
191. Tsagarakis S., Kontogeorgos G., Giannou P., Thalassinos N., Woolley J., Besser G. M., and Grossman A. (1992) Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Clin. Endocrinol. 37, 163-167.
192. Umegaki H., Yamada K., Naito M., Kameyama T., Iguchi A., and Nabeshiama T. (1996) Protective effect of interleukin-6 against the death of PC 12 cells caused by serum deprivation or by the addition of a calcium ionophore. Biochem. Pharmacol. 52, 911-916.
193. Van Snick J. (1990) Interleukin-6: an overview. Annu. Rev. Immunol. 8, 253-278.
194. Vandenabeele P. and Fiers W. (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1-/ IL-6-mediated 'acute phase response' in the brain? Immunol. Today 12, 217-219.
195. Vandesande F., Dierickx K., and De Mey J. (1977) The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis. Cell Tissue Res. 180, 443-452.
196. Vankelecom H., Carmeliet P., Van Damme J., Billiau A., and Denef C. (1989) Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49, 102-106.
197. Vege A., Rognum T. O., Scott H., Aasen A. O., and Saugstad O. D. (1995) SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Pædiatr. 84, 193-196.
198. Waage A., Halstensen A., Shalbaby R., Brandtzaeg P., Kierulf P., and Espevik T. (1989) Local production of tumor necrosis factor α interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170, 1859-1867.
199. Walker D. G., Kim S. U., and McGeer P. L. (1995) Complement and cytokine gene expression in cultured microglia derived for postmortem human brains. J. Neurosci. Res. 40, 478-493.
200. Wang X., Yue T-L., Young P. R., Carone F. C., and Feuerstein G. Z. (1995) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15, 166-171.
201. 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
202. Woodroofe M. N. (1995) Cytokine production in the central nervous system. Neurology 45 (suppl. 6), S6-S10.
203. Woodroofe M. N., Sarna G. S., Wadhwa M., Hayes G. M., Loughlin A. J., Tinker A., and Cuzner M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role of microglia in cytokine production. J. Neuroimmunol. 33, 227-236.
204. Xin L. and Blatteis C. M. (1992) Hypothalamic neuronal responses to interleukin-6 in tissue slices: effects of indomethacin and naloxone. Brain Res. Bull. 29, 27-35 (in press).
205. Yamabe T., Dhir G., Cowan E. P., Wolf A. L., Bergey G. K., Krumholz A., Barry E., Hoffman P. M., and Dhib-Jalbut S. (1994) Cytokine-gene expression in measles-infected adult human glial cells. J. Neuroimmunol. 49, 171-179.
206. Yamada M. and Hatanaka H. (1994) Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643, 173-180.
207. Yamada K, Kono K., Umegaki H., Yamada K., Iguchi A., Fukatsu T., Nakashima N., Nishiwaki H., Shimada Y., Sugita Y., Yamamoto T., Hasegawa T., and Nabeshima T. (1995) Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci. Lett. 186, 219-221.
208. Yamaguchi M., Matsuzaki N., Hirota K., Miyake A., and Tanizawa O. (1990) Interleukin 6 possibly induced by interleukin 1 beta in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinol. 122, 201-205.
209. Yamaguchi M., Yoshimoto Y., Komura H., Koike K., Matsuzaki N., Hirota K., and Tanizawa O. (1990) Interleukin 1 beta and tumour necrosis factor alpha stimulate the release of gonadotropin-releasing hormone and interleukin 6 by primary cultured rat hypothalamic cells. Acta Endocrinol. 123, 476-480.
210. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., and Kishimoto T. (1988) Cloning and expression of the human interleukin-6 (BSF-2/IFNβ 2) receptor. Science 241, 825-828.
211. Yan H. Q.; Banos M. A., Herregodts P., Hooghe R., and Hooghe-Peters E. L. (1992) Expression of interleukin (IL)-1β IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22, 2963-2971.
212. Yasin S. A., Costa A., Forsling M. L., and Grossman A. (1994) Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro. J. Neuroendocrinol. 6, 179-184.
213. Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T., Nakai S., and Kishimoto T. (1987) Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 6, 2939-2945.
214. Yeh T. S., Wang C. R., Jeng G. W., Lee G. L., Chen M. Y., Wang G. R., Lin K. T., Chuang C. Y., and Chen C. Y. (1994) The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement. Autoimmunity 18, 169-175.
215. Zalcman S., Green-Johnson J. M., Murray L., Nance D. M., Dyck D., and Anisman H. (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 643, 40-49.